Literature DB >> 4026677

Measurement of alternative blood flow in the porcine panniculus carnosus myocutaneous flap.

C W Cummings, R E Trachy.   

Abstract

The dependence of a transposed myocutaneous flap on its own vascular pedicle for survival is time-related. The number of days required to establish effective sustaining perfusion from the periphery was assessed. Based on flap perfusion with associated vascular compression as monitored by the laser Doppler and dermofluorometer, adequate perfusion levels occurred at days 7 to 10 in the pig panniculus carnosus myocutaneous flap. It was established that all flaps will survive independent of the vascular pedicle when the laser Doppler readings are above 40 mV and the dermofluorometric readings are above 20%. The establishment of this baseline information now allows for the investigation of pharmacologic manipulation of the blood flow to diminish the duration of dependence on the transposed vascular pedicle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026677     DOI: 10.1001/archotol.1985.00800110076006

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  3 in total

1.  From the panniculus carnosum (PC) to the superficial fascia system (SFS)

Authors:  P B Fodor
Journal:  Aesthetic Plast Surg       Date:  1993       Impact factor: 2.326

2.  Laser Speckle Contrast Imaging of the Blood Perfusion in Glabellar Flaps Used to Repair Medial Canthal Defects.

Authors:  Johanna V Berggren; Kajsa Tenland; Rafi Sheikh; Jenny Hult; Karl Engelsberg; Sandra Lindstedt; Malin Malmsjö
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021-11-08       Impact factor: 2.011

3.  Revascularization After H-plasty Reconstructive Surgery in the Periorbital Region Monitored With Laser Speckle Contrast Imaging.

Authors:  Johanna Berggren; Nazia Castelo; Kajsa Tenland; Karl Engelsberg; Ulf Dahlstand; John Albinsson; Rafi Sheikh; Sandra Lindstedt; Malin Malmsjö
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 May-Jun 01       Impact factor: 1.746

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.